FILIPAZZI, VIRGINIO
FILIPAZZI, VIRGINIO
Universita' degli Studi di MILANO
Single nucleotide polymorphisms to predict taxanes toxicities and effectiveness in cancer patients
2021 S. Demurtas, N. La Verde, S. Rota, G. Casazza, C. Montrasio, S. Cheli, M.S. Cona, D. Dalu, C. Fasola, S. Ferrario, V. Filipazzi, A. Gambaro, N. Tosca, E. Clementi
Efficacy and Safety of Anti-PD-1 Immunotherapy in Patients Aged ≥ 75 Years With Non–small-cell Lung Cancer (NSCLC) : An Italian, Multicenter, Retrospective Study
2020 A. Luciani, A. Marra, L. Toschi, D. Cortinovis, S. Fava, V. Filipazzi, A. Tuzi, G. Cerea, S. Rossi, V. Perfetti, A. Rossi, L. Giannetta, L. Sala, G. Finocchiaro, E.G. Pizzutilo, S. Carelli, F. Agustoni, M. Cergnul, S. Zonato, S. Siena, P. Bidoli, D. Ferrari
ABCB1 c.3435C > T polymorphism is associated with platinum toxicity: a preliminary study
2019 B. De Troia, D. Dalu, V. Filipazzi, L. Isabella, N. Tosca, S. Ferrario, A.R. Gambaro, L. Somma, C. Fasola, S. Cheli, E. Clementi, D. De Francesco, F.S. Falvella, M.T. Cattaneo
Granulocyte colony-stimulating factors used in clinical practice : PoloNord registry-based cohort Italian study
2014 D. Fagnani, L. Isa, M.F. Verga, P. Nova, C. Casartelli, V. Filipazzi, M. Danova, G. Farina, P. Pugliese, S. Fava, A. Bertolini, C. Cimminiello, P. Boracchi, G. Marano, C. Panzarino, POLONORD Group